2m 2m 2m 2m 2m 2m 2m
KYVERNA THERAP (KYTX)
NASDAQ
$7.91+$0.010 (+0.13%)
Price as of Jun 03, 2026 7:42 PM EDT- $518.0MMarket Cap
- 183.15%1-Year Change
- BiotechnologyIndustry
KYVERNA THERAP (KYTX)
$7.91+$0.010 (+0.13%)
KYTX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $7.90 | ||
Change | -$0.32 (-3.89%) | ||
Open | $8.20 | ||
High | $8.20 | ||
Low | $7.57 | ||
Previous Close | $8.22 | ||
Volume | 1,614,265 | ||
30-Day Average Volume | 899,098 | ||
1-Week Change | -8.25% | ||
1-Month Change | -10.94% | ||
1-Year Change | 183.15% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 60.8M | ||
Total Assets | $257.0M | ||
Market Cap | $518.0M | ||
Enterprise Value | $535.4M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$39.7M | ||
Free Cash Flow | -$41.6M | ||
EBIT | -$39.1M | ||
EBITDA | -$38.8M | ||
Net Working Capital | $212.1M | ||
EPS | -$0.66 | ||
Enterprise Value/EBITDA | -14 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 3 | ||
P/E | -13 | ||
PEG | -1 | ||
Price/Free Cash Flow | -12 | ||
Price/Operating Cash Flow | -12 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue